The Profit Motive Behind New Alzheimer’s Treatments

When Barbara Feuerstein, seventy-two, saw a Facebook ad offering a free blood test for Alzheimer’s disease, she jumped at the opportunity. The ad, placed by a research center, offered the test, recently by the Food and Drug Administration (FDA), as part of a to prevent the disease.